Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Gallant

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Medicinal Chemistry|August 20, 2004
Classification of kinase inhibitors using a Bayesian modelXiaoyang Xia, Edward G Maliski, Paul Gallant, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffoldManish Tandon, David L Coffen, Paul Gallant, et al.
Frontiers in Plant Science|March 20, 2023
Irrigation with primary wastewater alters wood anatomy and composition in willow <i>Salix miyabeana</i> SX67Ahmed Jerbi, Joan Laur, Kevin Lajoie, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Discovery of a potent and selective series of pyrazole bacterial methionyl-tRNA synthetase inhibitorsJohn Finn, Karen Mattia, Mike Morytko, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Nature Biotechnology|January 10, 2008
A quantitative analysis of kinase inhibitor selectivityMazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Journal of Medicinal Chemistry|August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsMichele H Potashman, James Bready, Angela Coxon, et al.
Journal of Medicinal Chemistry|January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinaseVictor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Journal of Medicinal Chemistry|January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitorBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Medicinal Chemistry|August 20, 2004
Classification of kinase inhibitors using a Bayesian modelXiaoyang Xia, Edward G Maliski, Paul Gallant, et al.
Bioorganic & Medicinal Chemistry Letters|March 31, 2004
Potent and selective inhibitors of bacterial methionyl tRNA synthetase derived from an oxazolone-dipeptide scaffoldManish Tandon, David L Coffen, Paul Gallant, et al.
Frontiers in Plant Science|March 20, 2023
Irrigation with primary wastewater alters wood anatomy and composition in willow <i>Salix miyabeana</i> SX67Ahmed Jerbi, Joan Laur, Kevin Lajoie, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2003
Discovery of a potent and selective series of pyrazole bacterial methionyl-tRNA synthetase inhibitorsJohn Finn, Karen Mattia, Mike Morytko, et al.
Bioorganic & Medicinal Chemistry Letters|December 18, 2007
N-(3-(phenylcarbamoyl)arylpyrimidine)-5-carboxamides as potent and selective inhibitors of Lck: structure, synthesis and SARHolly L Deak, John R Newcomb, Joseph J Nunes, et al.
Bioorganic & Medicinal Chemistry Letters|March 14, 2007
Synthesis, structural analysis, and SAR studies of triazine derivatives as potent, selective Tie-2 inhibitorsBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Nature Biotechnology|January 10, 2008
A quantitative analysis of kinase inhibitor selectivityMazen W Karaman, Sanna Herrgard, Daniel K Treiber, et al.
Journal of Medicinal Chemistry|August 19, 2007
Design, synthesis, and evaluation of orally active benzimidazoles and benzoxazoles as vascular endothelial growth factor-2 receptor tyrosine kinase inhibitorsMichele H Potashman, James Bready, Angela Coxon, et al.
Journal of Medicinal Chemistry|January 27, 2007
Alkynylpyrimidine amide derivatives as potent, selective, and orally active inhibitors of Tie-2 kinaseVictor J Cee, Brian K Albrecht, Stephanie Geuns-Meyer, et al.
Journal of Medicinal Chemistry|January 27, 2007
Evolution of a highly selective and potent 2-(pyridin-2-yl)-1,3,5-triazine Tie-2 kinase inhibitorBrian L Hodous, Stephanie D Geuns-Meyer, Paul E Hughes, et al.
Pageof 2